Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$98.56 - $119.91 $319,235 - $388,388
-3,239 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$91.91 - $110.37 $6,157 - $7,394
67 Added 2.11%
3,239 $355,000
Q2 2021

Aug 13, 2021

BUY
$86.24 - $95.92 $65,197 - $72,515
756 Added 31.29%
3,172 $297,000
Q1 2021

May 13, 2021

BUY
$71.83 - $95.48 $173,541 - $230,679
2,416 New
2,416 $222,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Seven One Seven Capital Management Portfolio

Follow Seven One Seven Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven One Seven Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Seven One Seven Capital Management with notifications on news.